Advertisement
Millions of much-needed testing kits for COVID-19 are on the way to clinics and labs nationwide

Millions of Coronavirus Test Kits Available Soon, Vice President Says

0
Last week, Pence said that all restrictions on coronavirus testing would be lifted
Among adults with atrial fibrillation

Apixaban Seems Safer Than Rivaroxaban for A-Fib

0
Lower rates seen for ischemic stroke or systemic embolism, GI bleeding or intracranial hemorrhage
In an Endocrine Society guideline update

Romosozumab Added to Guideline for Management of Osteoporosis

0
Drug recommended for postmenopausal women at very high fracture risk but not at high risk for heart disease, stroke
Anticholinergic burden is associated with adverse outcomes in a middle- to older-aged population

Anticholinergic Burden Tied to Adverse Effects in Middle Age

0
Identification of at-risk populations varies by scale used, which could impact clinical practice
Many opportunities have been identified for improving blood pressure control

Opportunities Identified for Improving BP Control

0
Based on EHR data, room for improvement found in BP control, health care processes such as meds intensification
A systemwide

Multipronged Postoperative Opioid Program Cuts Rx Length

0
Program includes mix of physician education, monitoring, and incentives to shorten Rx length for surgical patients
Rotavirus vaccination seems not to be associated with type 1 diabetes in children

Rotavirus Vaccination, Type 1 Diabetes Not Linked in Children

0
No significant correlation seen for children fully or partially exposed to rotavirus vaccine versus unexposed
Gabapentin appears to be efficacious for the treatment of alcohol use disorder

Gabapentin Seems Efficacious for Alcohol Use Disorder

0
Positive effect seen on heavy drinking days, total abstinence, especially in high alcohol withdrawal group
Average employer-sponsored insurance spending rose to $5

2018 Health Care Spending Up Due to Higher Prices

0
2018 uptick in utilization first seen in years, but impact dwarfed by price increases
U.S. officials are cracking down on companies selling fraudulent products that claim to prevent or treat the new coronavirus.

Fraudulent Coronavirus ‘Meds’ Targeted by FDA

0
Unapproved drugs pose significant health risks and violate federal law, the FDA notes